Literature DB >> 11858487

Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses.

Miao-Liang Liu1, Shelley Nakaya, Arthur R Thompson.   

Abstract

Heteroduplex screening identified 74 small mutations in the factor VIII genes of 72 families with hemophilia A. In addition, patients from 3 families with high titer inhibitors had partial gene deletions and 5 unrelated families that were negative for heteroduplex formation had a mutation on direct sequencing. The latter had mild hemophilia A with an inhibitor, and sequencing their exon 23 fragments found a transition predicting a recurrent Arg2150 to His. Of 69 distinct mutations (including the 3 partial gene deletions), 47 are novel. Of small mutations, 51 were missense (one possibly a normal variant and two that could also alter splicing) at 39 sites, 13 were small deletions or insertions (3 inframe and one a normal variant in an intron), 13 were nonsense at 12 sites and 2 altered intron splice junctions. In 24 families, at least one affected member had evidence for an alloimmune response to factor VIII: of these, 11 were associated with missense mutations. In 14 families, de novo origin was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11858487

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A.

Authors:  Ravi R Thiagarajan; Stephen J Roth; Steven Margossian; Andrew S Mackie; Ellis J Neufeld; Peter C Laussen; Joseph M Forbess; Elizabeth D Blume
Journal:  Intensive Care Med       Date:  2003-04-29       Impact factor: 17.440

2.  HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.

Authors:  R A Ettinger; E A James; W W Kwok; A R Thompson; K P Pratt
Journal:  Haemophilia       Date:  2010-05       Impact factor: 4.287

3.  Mutation analysis of factor VIII in Korean patients with severe hemophilia A.

Authors:  Chur-Woo You; Hee-Sook Son; Hee Jin Kim; Eui-Jeon Woo; Soon-Ae Kim; Haing-Woon Baik
Journal:  Int J Hematol       Date:  2010-06-10       Impact factor: 2.490

4.  Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A.

Authors:  Arupa Ganguly; Tanya Dunbar; Peiqin Chen; Lynn Godmilow; Tapan Ganguly
Journal:  Hum Genet       Date:  2003-07-12       Impact factor: 4.132

5.  Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites.

Authors:  Adoración Venceslá; María Angeles Corral-Rodríguez; Manel Baena; Mónica Cornet; Montserrat Domènech; Montserrat Baiget; Pablo Fuentes-Prior; Eduardo F Tizzano
Journal:  Blood       Date:  2008-01-09       Impact factor: 22.113

Review 6.  Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.

Authors:  Ai Hong Zhang; Jonathan Skupsky; David W Scott
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

7.  In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.

Authors:  George Priya Doss C
Journal:  J Biomed Sci       Date:  2012-03-16       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.